MENU
STOK
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?
Profile
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
646.51M
P/E Ratio
N/A
Total Cash
281.98M
Projected Growth
N/A
Total Debt
2.28M
Revenue
15.16M
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
5.36
Total Debt/Equity
N/A
Revenue/Share
0.32 USD as % of share price
Fundamentals
STOK
Capitalization
647M
P/E Ratio
N/A
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
282M
Total Cash/Share
5.36
Total Debt
2.28M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.32%
Revenue
15.2M
ROE
N/A
Book Value
243M
P/B Ratio
2.66
Cash Flow
N/A
Earnings
-2.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
6.67
Current Revenue Per Employee
43918.18
Dividends Per Share - Security
N/A
EBITDA
-112.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.68
Shares Held By Institutions
900M
Shares Outstanding - Current
52.6M
Total Liabilities
65M
Total Volume MTD
N/A
Value
N/A
Gain YTD
138.023
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of treatments for genetic diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com